Rights offering for $55 million
Company: Core Scientific
The claim, verbatim
Holders of pre-emergence common stock were granted rights to purchase up to $55 million of new common stock pursuant to the reorganization plan
Source (primary)
Core Scientific SC 13D/A filed 2024-02-21 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “holders of the Issuer's Old Common Stock as of November 16, 2023 were granted the right to participate in a rights offering (the " Rights Offering ") for the purchase, on a pro rata basis, of up to $55 million of Common Stock to be issued pursuant to the Plan.”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific SC 13D/A filed 2024-02-21
Quote: “holders of the Issuer's Old Common Stock as of November 16, 2023 were granted the right to participate in a rights offering (the " Rights Offering ") for the purchase, on a pro rata basis, of up to $55 million of Common Stock to be issued pursuant to the Plan.”